Significant correlations (P ≤ 0.05) were found between JUN expression levels and survival in patients with liver hepatocellular carcinoma (LIHC), esophageal squamous carcinoma (ESCA) and rectal adenocarcinoma (READ), as shown in Figures 5A–D. This evidence concerns the gene JUN and reading.